South Korean Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

2 companies

HansBiomed

Market Cap: ₩445.0b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

A042520

₩31,200.00

-6.7%

330.9%

3billion

Market Cap: ₩437.4b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

A394800

₩13,770.00

12.0%

105.8%